Live Better With Blog

A new treatment for leukaemia developed in Australia has been fast-tracked for use in the US and EU. The drug Venetoclax is a targeted therapy designed to prevent the perpetual growth and replication of cancer cells.

By blocking BCL2, a protein produced by cancer cells making them immortal, Venetoclax stops the cells from being able ...

NHS to use radioactive drugs to treat Prostate Cancer

A new radioactive treatment for prostate cancer that has spread to the bones has received approval by NICE for use in the NHS. The drug, Xofigo, will be available from December 2016 and is expected to help reduce bone pain and fractures for hundreds of men across the UK.

Xofigo is made from Radium-223 dichloride and ...

The use of chemotherapy in England is being scrutinised this week after a study by Public Health England (PHE) found that almost  1,400 patients with either breast or lung cancer died in England in 2014 within a month of being given chemotherapy, suggesting they suffered harm, rather than benefited, from being given chemotherapy.

It's ...

Menopause: Combined HRT can triple risk of breast cancer

Hormone replacement therapy (HRT) helps minimise the more troublesome symptoms of menopause such as hot flushes, disrupted sleep, migraines, mood changes and depression. That is why NICE, the National Institute of Health and Care Excellence, changed guidance to encourage more doctors to prescribe HRT claiming too many menopausal women had been left suffering in silence ...

Cancer drug companies drop prices to get NHS approval

Tougher negotiations with pharmaceutical firms means the NHS can now benefit from cheaper cancer drugs. This comes as a much needed  relief to patients after closure of the Cancer Drug Fund, worth £340 million per year.

In order for the NHS to provide a drug free, of charge, to the nation it must first decide ...

Scientists have developed a new test that is able to predict the risk of breast cancer spreading more accurately and quickly than the current NICE- approved, NHS equivalent. It could be used to make better decisions about treatment options especially for low risk women who could be spared unnecessary chemotherapy.

The new test, EndoPredict, analyses ...

Macmillan’s Cancer Comparison: 1970s to Now

Yesterday, Macmillan published a fascinating report on the changes in cancer care over the last 40 years, comparing diagnosis, treatment and survival in the 1970s to now. Live Better With’s Dr Zahra Neshat has read the 23 page article article and picked out the most important and interesting parts to give you a useful summary of the improvements in cancer care, and those still needed.

A study funded by Ovarian Cancer Action has discovered a protein that brings us closer to early detection and better treatment of Ovarian cancer. The discovery of the protein, SOX2, means that the disease could be spotted years before symptoms arise, giving women a better chance of successful treatment.

Currently, ovarian cancer can grow for ...

Page 1 of 2